Familial mediterranean fever
H Ozdogan, S Ugurlu - La Presse Médicale, 2019 - Elsevier
Familial Mediterranean Fever (FMF) is the oldest and the most frequent of all described
hereditary periodic fever syndromes. The populations originating from Mediterranean basin carry …
hereditary periodic fever syndromes. The populations originating from Mediterranean basin carry …
Behçet syndrome: is it one condition?
H Yazici, S Ugurlu, E Seyahi - Clinical reviews in allergy & immunology, 2012 - Springer
Behçet's syndrome (BS) is a disease of unknown etiology, and as such, there have been
efforts to classify BS within the popular nosological identities of the times such as seronegative …
efforts to classify BS within the popular nosological identities of the times such as seronegative …
Canakinumab for the treatment of familial Mediterranean fever
H Ozdogan, S Ugurlu - Expert review of clinical immunology, 2017 - Taylor & Francis
… Health-related QoL (CHQ-PF50) and physician’s global assessment improved significantly
as well. Eleven adverse events were observed in four children. All were mild except one, who …
as well. Eleven adverse events were observed in four children. All were mild except one, who …
[HTML][HTML] Willingness to get the COVID-19 vaccine among patients with rheumatic diseases, healthcare workers and general population in Turkey: a web-based survey
… -normally distributed variables and then Dunn’s test with Bonferroni correction was used
for … Pearson’s chi-square test. Reliability of the CAS was assessed using Cronbach’s alpha …
for … Pearson’s chi-square test. Reliability of the CAS was assessed using Cronbach’s alpha …
Vascular involvement in Behçet's syndrome: a retrospective analysis of associations and the time course
K Tascilar, M Melikoglu, S Ugurlu, N Sut… - …, 2014 - academic.oup.com
Objective. Some features of Behçet’s syndrome (BS) tend to go together. We aimed to explore
the association and timing of various vascular events in both the venous and the arterial …
the association and timing of various vascular events in both the venous and the arterial …
Atherosclerosis in Takayasu arteritis
E Seyahi, S Ugurlu, R Cumali, H Balci… - Annals of the …, 2006 - ard.bmj.com
Objective: Chronic inflammatory diseases such as systemic lupus erythematosus (SLE) and
rheumatoid arthritis are associated with accelerated atherosclerosis. We hypothesised that …
rheumatoid arthritis are associated with accelerated atherosclerosis. We hypothesised that …
Targeted resequencing implicates the familial Mediterranean fever gene MEFV and the toll-like receptor 4 gene TLR4 in Behçet disease
…, E Seyahi, Y Özyazgan, S Ugurlu… - Proceedings of the …, 2013 - National Acad Sciences
… Meta-analyses (Stouffer’s weighted Z-method) of the Japanese and Turkish association … kit
(Illumina) according to manufacturer’s protocol with modification. Fragmented PCR amplicons …
(Illumina) according to manufacturer’s protocol with modification. Fragmented PCR amplicons …
[HTML][HTML] Mushroom poisoning: retrospective analysis of 294 cases
… The most common toxic symptoms recorded in this study’s subjects, including nausea,
vomiting, fatigue, abdominal pain, dizziness, diarrhea, headache and loss of consciousness, have …
vomiting, fatigue, abdominal pain, dizziness, diarrhea, headache and loss of consciousness, have …
[HTML][HTML] Increasing peripapillary atrophy is associated with progressive glaucoma
H Uchida, S Ugurlu, J Caprioli - Ophthalmology, 1998 - Elsevier
OBJECTIVE: This study aimed to determine the incidence and degree of progression of
peripapillary atrophy in progressive and nonprogressive glaucoma. STUDY DESIGN: A …
peripapillary atrophy in progressive and nonprogressive glaucoma. STUDY DESIGN: A …
Treatment options in colchicine resistant familial Mediterranean fever patients: thalidomide and etanercept as adjunctive agents.
E Seyahi, H Ozdogan, S Celik, S Ugurlu… - Clinical and …, 2006 - europepmc.org
Objective Regular colchicine treatment cannot control the typical febrile attacks of FMF in
about 5-10% of the compliant patients. Here we report the effect of thalidomide and etanercept …
about 5-10% of the compliant patients. Here we report the effect of thalidomide and etanercept …